Facet browsing currently unavailable
Page 1 of 6154 results
Sort by: relevance publication year
Industry concern over EU hepatotoxicity guidance JOURNAL ARTICLE published September 2008 in Nature Reviews Drug Discovery |
Towards a broad-spectrum flavivirus vaccine JOURNAL ARTICLE published February 2021 in Nature Reviews Drug Discovery |
Targeting tumour-associated bacteria JOURNAL ARTICLE published December 2023 in Nature Reviews Drug Discovery |
Bacteria tag tumours for CAR-T cell attack JOURNAL ARTICLE published December 2023 in Nature Reviews Drug Discovery |
Repurposing SGLT2 inhibitors JOURNAL ARTICLE published January 2019 in Nature Reviews Drug Discovery |
Understanding long-lasting ketamine effects JOURNAL ARTICLE published December 2023 in Nature Reviews Drug Discovery |
The acute myeloid leukaemia market JOURNAL ARTICLE published April 2020 in Nature Reviews Drug Discovery |
Genome editing to 're-write' wrongs JOURNAL ARTICLE published October 2018 in Nature Reviews Drug Discovery |
Why do oncology drugs fail to gain US regulatory approval? JOURNAL ARTICLE published July 2015 in Nature Reviews Drug Discovery |
Fine-tuning antibody–drug conjugates JOURNAL ARTICLE published March 2014 in Nature Reviews Drug Discovery |
Author Correction: Bridging the gap between innovation and later-stage financing for biotech in Europe JOURNAL ARTICLE published November 2023 in Nature Reviews Drug Discovery |
Protein degradation reaches further out JOURNAL ARTICLE published September 2020 in Nature Reviews Drug Discovery |
Synthesizing portimines JOURNAL ARTICLE published November 2023 in Nature Reviews Drug Discovery |
Buy buy bispecific antibodies JOURNAL ARTICLE published November 2011 in Nature Reviews Drug Discovery |
FDA approves first hypoxia-inducible factor prolyl hydroxylase inhibitor JOURNAL ARTICLE published March 2023 in Nature Reviews Drug Discovery |
Late-stage osteoporosis drugs illustrate challenges in the field JOURNAL ARTICLE published October 2009 in Nature Reviews Drug Discovery |
Orphan drug designation and development in Japan: 25 years of experience and assessment JOURNAL ARTICLE published December 2021 in Nature Reviews Drug Discovery |
Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention JOURNAL ARTICLE published 1 April 2004 in Nature Reviews Drug Discovery |
Acyl-lysine reader inhibitor blocks AML progression JOURNAL ARTICLE published November 2022 in Nature Reviews Drug Discovery |
Identifying selective PI3KC2α inhibitors JOURNAL ARTICLE published November 2022 in Nature Reviews Drug Discovery |